Last $0.0009 USD
Change Today 0.00 / 0.00%
Volume 0.0
SAFC On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for safecode drug technologies c (SAFC)

Currency in
Millions of US Dollars
As of:Dec 31
2010
Dec 31
2011
Dec 31
2012
--
--
4 Year
Trend
Cost of Goods Sold0.1------
GROSS PROFIT-0.1------
Selling General & Admin Expenses, Total0.00.00.2--
Other Operating Expenses----0.0--
OTHER OPERATING EXPENSES, TOTAL0.00.00.2--
OPERATING INCOME-0.10.0-0.2--
Interest Expense----0.0--
NET INTEREST EXPENSE----0.0--
Currency Exchange Gains (Loss)----0.0--
EBT, EXCLUDING UNUSUAL ITEMS-0.10.0-0.2--
Gain (Loss) on Sale of Investments----0.0--
Other Unusual Items, Total-----1.8--
EBT, INCLUDING UNUSUAL ITEMS-0.10.0-2.1--
Earnings from Continuing Operations-0.10.0-2.1--
NET INCOME-0.10.0-2.1--
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-0.10.0-2.1--
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-0.10.0-2.1--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAFC:US $0.00 USD 0.00

SAFC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SAFC.
View Industry Companies
 

Industry Analysis

SAFC

Industry Average

Valuation SAFC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAFECODE DRUG TECHNOLOGIES C, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.